Doxorubicin Pliva

Doxorubicin Hydrochloride is a chemotherapy medication used to treat various cancers. This intravenous drug is manufactured by Pliva Hrvatska D.O.O. and is available in the EU market.

Doxorubicin Hydrochloride is primarily used in cancer treatment, targeting a range of malignancies. It works by interfering with the growth of cancer cells, making it a key component in chemotherapy regimens. Patients often wonder, 'What is Doxorubicin used for?' and the answer lies in its ability to combat cancerous growths in the body.

Common effects of Doxorubicin Hydrochloride may include nausea, fatigue, and hair loss. Some patients also experience changes in skin color or sensitivity to sunlight. These effects can vary widely among individuals and are not exhaustive.

Doxorubicin Hydrochloride should be handled with care, as it is a potent medication. It is crucial to follow healthcare provider instructions for administration and storage. Pregnant women and individuals with certain heart conditions should exercise caution.

Doxorubicin Hydrochloride may interact with other medications, including those that affect the heart or immune system. It is important to disclose all current medications to a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also impact its effectiveness.